Zofia CEO Briefing at Food and Drug Administration

I just Imagewanted to take a moment and thank EVERYONE for the positive support and response to the hearing at the FDA on 25 February 2013 – Considerations Regarding Food and Drug Administration Review and Regulation of Drugs for the Treatment of Amyotrophic Lateral Sclerosis; Public Hearing. 

The response was overwhelming and appreciated.  I am so grateful for the way the entire ALS community came together to have their voices heard – live, written statements, and on social media.

If you missed the hearing – you can view the entire webcast here (and find information on how to submit your own statement) : http://www.fda.gov/Drugs/NewsEvents/ucm339833.htm 


Thank you!

Michelle Farr

CEO, Zofia Consulting